This informative webinar provides details of the Australian Governments implementation of a suite of regulatory changes regarding pharmaceutical opioids .
This is in an effort to reduce the harm caused by these medicines in the community while ensuring safe access for patients who need them. In addition, changes to the PBS came into effect from 1 June 2020 to support the intent of the underlying regulatory changes. In this webinar we will equip you with the tools and resources to support the safe implementation of any changes in your practice to reflect the new circumstances.
Presenters
You will receive expert advice from Dr Grant Pegg from the Therapeutic Goods Administration (TGA), who will discuss the federal regulatory changes.
Sophia Palmer, Assistant Secretary of the Pharmacovigilance and Special Access Branch of the Therapeutic Goods Administration (TGA) who will provide an overview of the PBS changes.
Dr Peter Simpson, GP and MIPS clinico legal adviser will provide an overview of the key clinico legal messages
